JPT/NB Histone Peptide H3 14:30 R17me2s (H3.123)/SP-His_nb_085/

价格
¥2574.00
货号:SP-His_nb_085
浏览量:38
品牌:JPT
服务
全国联保
正品保证
正规发票
签订合同
商品描述

NBHistonePeptideH314:30R17me2s(H3.123)

ProductCode:SP-His_nb_085

SyntheticHistonepeptidecarrying1modification(R17me2s)derivedfromhumanHistoneH3.123(Swiss-ProtIDs:Q71DI3,P84243,P68431).
Aminoacidsequence:H-KAP-Arg(Me2s)-KQLATKAARKSAP-NH2
Amount:1vialcontaining30nmol(approx.100µg)
Purity:>70%(HPLC-MS)
Deliveryformat:Freeze-driedinambertypeglassvials
Application(s):Enzymekinetics,SubstrateSpecifity,Substrateidentification,Competitionexperiments,Co-crystallization,NMRstudies
Indication(s)/Topic(s):Cancer,Kinase,Methyltransferase,Acetyltransferase,Histones,Phosphatase,Generegulationandexpression,Epigenetics,Cellsignaling,Nucleosome
Deliverytime:10-12days

JPT"sNon-BiotinylatedHistoneCodePeptides
Inadditiontoourbiotinylatedhistonepeptides,JPToffersanon-biotinylatedlibraryofsyntheticposttranslationallymodifiedandunmodifiedhumanhistonepeptidesthatisnowavailableasindividualpeptides.Thepeptidelibraryconsistsof160peptidesfromdifferenthistonefamilies.PeptidescarryPTMsatreportedsites(e.g.acetylation,methylation,phosphorylation...)invariouscombinationsrepresentingnaturalvariants.
JPT"shighlyskilledandcommittedscientificstaffensuresthatthemostappropriatemethodsandtechniquesareselectedforeverysynthesisproject.AllofJPT"scatalogpeptidesareprovidedwithHPLC-MSanalysestoconfirmtheidentityanddemonstratethehighqualityofourpeptides.

BenefitsofJPT"sHistoneCodePeptides
-WholeproductionperformedinaregulatedEuropeanenvironmentaccordingtoDINENISO9001:2015&GCLPstandards;auditswelcome!
-Forhigh-throughputscreeningJPT"sHistoneCodePeptideMicroarrayisavailabledisplayingmorethan3000peptides.
-ProvisionoffreezedriedaliquotsforenhancedstABIlity
-Proventrackrecordformanyapplications

NBHistonePeptideH314:30R17me2s(H3.123)

SelectedReferencesforHistonePeptideTools
"HistoneH2AandH4N-TerminalTailsarePositionedbytheMEP50WD-RepeatProteinforEfficientMethylationbythePRMT5ArginineMethyltransferase"
Burgosetal.,J.Biol.Chem.(2015)-PMID:25713080
"H3K23me2isaNewHeterochromaticMarkinCaenorhaBDitiselegans"

Vandammeetal., NucleicAcidsRes.(2015)-PMID:26476455
"StructureoftheArginineMethyltransferasePRMT5-MEP50RevealsaMechanismforSubstrateSpecificity"
Hoetal.PLOSONE(2013)-PMID:23451136
"UseofHigh-DensityHistonePeptideArraysforParsingtheSpecificityofaHistone-ModifyingEnzymeComplex"
Shechteretal,ApplicationNote(2013)(fulltext)
"ComprehensivePeptideMicroarraysforHistoneResearch"
Schnatbaumetal,32thEPS(2012)(fulltext)

ApplicationNotes
"UseofHigh-DensityHistonePeptideArraysforParsingtheSpecificityofaHistone-ModifyingEnzymeComplex"
Shechteretal.ApplicationNote(2013)(fulltext)
"ComprehensiveCharacterizationofAntibodiesDirectedtowardsEpigeneticHistone-Modifications"
Maschetal.ApplicationNote(2015)(fulltext)

TestimonialforHistoneCodePeptideMicroarray
"JPT"snewextremelyhigh-densityhistonepeptidearrayisadramaticleapforwardforanalysisofthehistonecodehypothesis.Thecompletesequencecoverageacrosscorehistonesandhistonevariantsaswellasthepresenceofcommonandrarehistonepost-translationalmodifications "aloneandincombination"makesthisanunparalleledtoolforstudyingthe"writers"and"readers"ofthehistonecode.MylaboratoryhasusedthesearraystoaskthesequenceandPTMdependenceofahistonewriterenzymeandwehavediscoveredanactivityspecifyingcodethatwillkeepusbusyforyearstocome."
DavidShechter,PhD,DepartmentofBiochemistry,AlbertEinsteinCollegeofMedicine,YU(NY,USA)

NBHistonePeptideH314:30R17me2s(H3.123)

TechnicalData:
HistoneFamilyHistoneH3
ModificationMethylation
SequencePositionTail(1-42)
IsoformH3.1
H3.2
H3.3
BiotinylationNoBiotin
ApplicationSubstrateidentification
ProteinNameHistones
OrganismHomosapiens(Human)
Indication/TopicAcetyltransferase
Epigenetics
Kinase
Numberofpeptides

FurtherInformation:
Amount1vialcontaining30nmol(approx.100µg)
SpecificationsSyntheticHistonepeptidecarrying1modification
DocumentationProductDatasheet
Swiss-ProtID
Q71DI3, 
P84243, 
P68431
NCBI
SequenceH-KAP-Arg(Me2s)-KQLATKAARKSA
P-NH2
JPT肽技术具有多种独特的基于肽技术允许系统组和蛋白质组跨越B细胞和T细胞的生物标志物的发现,免疫监测和临床开发的免疫治疗和疫苗。我们的工具和专有技术已成功用于各种项目中,从而在癌症,感染,自身免疫性疾病和过敏等适应症中采用了新颖的方法。